logo

For the Inventor, By the Inventor

Lyngby, Denmark

Lena Tagmose

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 38(Granted Patents)


Location History:

  • Valby, DK (2018 - 2020)
  • Lyngby, DK (2016 - 2021)

Company Filing History:

goldMedal13 out of 506 
 
H. Lundbeck A/s
 patents

Years Active: 2016-2024

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12129289 - Antibodies specific for hyperphosphorylated tau and methods of use thereof (2024-10-29),
2. 11111290 - Antibodies specific for hyperphosphorylated tau and methods of use thereof (2021-09-07),
3. 10647762 - Antibodies specific for hyperphosphorylated tau and methods of use thereof (2020-05-12),
4. 10603310 - 2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors (2020-03-31),
5. 10487142 - Antibodies specific for hyperphosphorylated tau and methods of use thereof (2019-11-26),
6. 10472415 - Antibodies specific for hyperphosphorylated tau and methods of use (2019-11-12),
7. 10059669 - 2-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treating alzheimer's disease (2018-08-28),
8. 10058540 - 2-amino-5,5-difluoro-6-(fluoromethyl)-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors (2018-08-28),
9. 10045974 - 2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors (2018-08-14),
10. 10011596 - 2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors (2018-07-03),
11. 10004738 - Combination treatment comprising administration of 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines (2018-06-26),
12. 9353084 - 2-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's disease (2016-05-31),
13. 9346797 - 2-amino 6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors (2016-05-24),
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…